We are live on ! Find out more
IMPV

Imperva, Inc.
IMPV

Delisted

IMPV was delisted on the 9th of January, 2019.

175 hedge funds and large institutions have $1.37B invested in Imperva, Inc. in 2017 Q4 according to their latest regulatory filings, with 32 funds opening new positions, 61 increasing their positions, 59 reducing their positions, and 28 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 12 (+1)

24% more call options, than puts

Call options by funds: $6.64M | Put options by funds: $5.36M

14% more first-time investments, than exits

New positions opened: 32 | Existing positions closed: 28

2% more funds holding

Funds holding: 171175 (+4)

3% more repeat investments, than reductions

Existing positions increased: 61 | Existing positions reduced: 59

5% less capital invested

Capital invested by funds: $1.44B → $1.37B (-$71.1M)

Holders
175
Holders Change
+4
Holders Change %
+2.34%
% of All Funds
3.97%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
32
Increased
61
Reduced
59
Closed
28
Calls
$6.64M
Puts
$5.36M
Net Calls
+$1.29M
Net Calls Change
-$3.01M
Name Holding Trade Value Shares
Change
Change in
Stake
EC
1
Eminence Capital
New York
$115M -$819K -19,644 -0.7%
BlackRock
2
BlackRock
New York
$107M -$1.86M -44,745 -2%
Vanguard Group
3
Vanguard Group
Pennsylvania
$105M +$6.97M +167,283 +7%
EM
4
Elliott Management
New York
$84.6M -$4.91M -117,774 -5%
CS
5
Credit Suisse
Switzerland
$56.4M +$216K +5,192 +0.4%
EAM
6
Eagle Asset Management
Florida
$52.9M +$1.39M +33,268 +3%
RC
7
RGM Capital
Florida
$51.1M +$53.6M +1,286,507 New
ClearBridge Investments
8
ClearBridge Investments
New York
$50.6M +$421K +10,099 +0.8%
EMG
9
ETF Managers Group
New Jersey
$50.4M +$7.37M +176,840 +17%
Alyeska Investment Group
10
Alyeska Investment Group
Illinois
$42.7M +$7.01M +168,305 +19%
Renaissance Technologies
11
Renaissance Technologies
New York
$31.7M +$11.8M +283,700 +55%
Millennium Management
12
Millennium Management
New York
$30.9M -$505K -12,108 -2%
State Street
13
State Street
Massachusetts
$26.4M +$1.25M +29,900 +5%
Bank of America
14
Bank of America
North Carolina
$26.4M -$3.22M -77,234 -10%
NRC
15
North Run Capital
Massachusetts
$25M +$1.54M +37,058 +6%
JP Morgan Chase
16
JP Morgan Chase
New York
$22.8M -$21.7M -521,412 -48%
PAMU
17
Pictet Asset Management (UK)
United Kingdom
$20.3M +$5.09M +122,144 +31%
Deutsche Bank
18
Deutsche Bank
Germany
$20.2M +$2.83M +67,854 +15%
RCAMU
19
Rothschild & Co Asset Management US
Connecticut
$20.1M +$21.1M +505,916 New
Northern Trust
20
Northern Trust
Illinois
$16.5M -$104K -2,498 -0.6%
Caisse de Depot et Placement du Quebec (CDPQ)
21
Caisse de Depot et Placement du Quebec (CDPQ)
Quebec, Canada
$16.5M -$2.45M -58,900 -12%
Citigroup
22
Citigroup
New York
$14.7M +$30.2K +725 +0.2%
AAM
23
Alpine Associates Management
Florida
$14.1M +$1.06M +25,400 +8%
Two Sigma Advisers
24
Two Sigma Advisers
New York
$14.1M +$1.56M +37,400 +12%
EA
25
Emerald Advisers
Pennsylvania
$13.6M -$13.2M -315,593 -48%

IMPV Hedge Fund Activity: Q4 2017 in Review

175 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Imperva, Inc. (IMPV) for Q4 2017, worth a combined $1.37B — down 4.9% from $1.44B a quarter earlier.

Buyers outnumbered sellers: 32 funds opened new IMPV positions and 28 closed out — a net gain of 4 holders — while 61 added to existing stakes and 59 trimmed.

The largest buyer was RGM Capital, opening a new position worth an estimated $53.6M. The largest seller was JP Morgan Chase, cutting an estimated $21.7M.

  • 175 institutional investors held Imperva, Inc. (IMPV) as of Q4 2017, up from 171 in Q3 2017.
  • Funds reported $1.37B of Imperva, Inc. stock for Q4 2017, down 4.9% quarter-over-quarter.
  • 32 funds opened new Imperva, Inc. positions in Q4 2017 and 28 closed out, a net change of +4 holders.
  • The largest Imperva, Inc. buyer in Q4 2017 was RGM Capital, an estimated $53.6M added.
  • The largest Imperva, Inc. seller in Q4 2017 was JP Morgan Chase, an estimated $21.7M sold.

Based on aggregated 13F filings for Q4 2017.